nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2D6—Lomustine—brain cancer	0.122	0.197	CbGbCtD
Mexiletine—CYP1A2—Carmustine—brain cancer	0.121	0.195	CbGbCtD
Mexiletine—CYP2D6—Hydroxyurea—brain cancer	0.0923	0.149	CbGbCtD
Mexiletine—CYP3A4—Temozolomide—brain cancer	0.0911	0.147	CbGbCtD
Mexiletine—CYP3A4—Lomustine—brain cancer	0.0775	0.125	CbGbCtD
Mexiletine—CYP2E1—Etoposide—brain cancer	0.0618	0.0997	CbGbCtD
Mexiletine—CYP1A2—Etoposide—brain cancer	0.0357	0.0577	CbGbCtD
Mexiletine—CYP3A4—Etoposide—brain cancer	0.0187	0.0302	CbGbCtD
Mexiletine—Pulmonary toxicity—Lomustine—brain cancer	0.0185	0.0711	CcSEcCtD
Mexiletine—Pulmonary toxicity—Procarbazine—brain cancer	0.0117	0.0451	CcSEcCtD
Mexiletine—Pulmonary fibrosis—Lomustine—brain cancer	0.00952	0.0367	CcSEcCtD
Mexiletine—Lung infiltration—Lomustine—brain cancer	0.00893	0.0344	CcSEcCtD
Mexiletine—Pulmonary toxicity—Carmustine—brain cancer	0.00733	0.0282	CcSEcCtD
Mexiletine—SCN10A—ganglion—brain cancer	0.00483	0.0654	CbGeAlD
Mexiletine—Pulmonary fibrosis—Hydroxyurea—brain cancer	0.00468	0.018	CcSEcCtD
Mexiletine—Lung infiltration—Hydroxyurea—brain cancer	0.00439	0.0169	CcSEcCtD
Mexiletine—SCN2A—hindbrain—brain cancer	0.0038	0.0515	CbGeAlD
Mexiletine—Pulmonary fibrosis—Carmustine—brain cancer	0.00378	0.0146	CcSEcCtD
Mexiletine—Nystagmus—Procarbazine—brain cancer	0.00372	0.0143	CcSEcCtD
Mexiletine—Pulmonary fibrosis—Temozolomide—brain cancer	0.00366	0.0141	CcSEcCtD
Mexiletine—Lung infiltration—Carmustine—brain cancer	0.00355	0.0137	CcSEcCtD
Mexiletine—Visual disturbance—Lomustine—brain cancer	0.00321	0.0124	CcSEcCtD
Mexiletine—Pulmonary fibrosis—Etoposide—brain cancer	0.00293	0.0113	CcSEcCtD
Mexiletine—Ataxia—Lomustine—brain cancer	0.00286	0.011	CcSEcCtD
Mexiletine—AHR—telencephalon—brain cancer	0.00239	0.0323	CbGeAlD
Mexiletine—SCN2A—brainstem—brain cancer	0.00218	0.0295	CbGeAlD
Mexiletine—Visual impairment—Lomustine—brain cancer	0.00203	0.00781	CcSEcCtD
Mexiletine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00201	0.0427	CbGpPWpGaD
Mexiletine—SCN9A—pituitary gland—brain cancer	0.00199	0.027	CbGeAlD
Mexiletine—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00197	0.0419	CbGpPWpGaD
Mexiletine—AHR—pituitary gland—brain cancer	0.00194	0.0263	CbGeAlD
Mexiletine—Speech disorder—Carmustine—brain cancer	0.00193	0.00745	CcSEcCtD
Mexiletine—SCN2A—telencephalon—brain cancer	0.00193	0.0262	CbGeAlD
Mexiletine—AHR—medulla oblongata—brain cancer	0.00188	0.0254	CbGeAlD
Mexiletine—Speech disorder—Temozolomide—brain cancer	0.00187	0.0072	CcSEcCtD
Mexiletine—SCN10A—telencephalon—brain cancer	0.00186	0.0252	CbGeAlD
Mexiletine—Alopecia—Lomustine—brain cancer	0.00186	0.00716	CcSEcCtD
Mexiletine—Ataxia—Procarbazine—brain cancer	0.00182	0.00699	CcSEcCtD
Mexiletine—SCN4A—pituitary gland—brain cancer	0.00178	0.0241	CbGeAlD
Mexiletine—SCN9A—midbrain—brain cancer	0.00176	0.0238	CbGeAlD
Mexiletine—AHR—midbrain—brain cancer	0.00171	0.0232	CbGeAlD
Mexiletine—SCN9A—spinal cord—brain cancer	0.00171	0.0232	CbGeAlD
Mexiletine—Coordination abnormal—Carmustine—brain cancer	0.00169	0.00653	CcSEcCtD
Mexiletine—AHR—spinal cord—brain cancer	0.00167	0.0227	CbGeAlD
Mexiletine—Dysphagia—Procarbazine—brain cancer	0.00167	0.00643	CcSEcCtD
Mexiletine—Leukopenia—Lomustine—brain cancer	0.00164	0.00632	CcSEcCtD
Mexiletine—Coordination abnormal—Temozolomide—brain cancer	0.00164	0.00631	CcSEcCtD
Mexiletine—Pancreatitis—Procarbazine—brain cancer	0.00164	0.0063	CcSEcCtD
Mexiletine—Sweating increased—Procarbazine—brain cancer	0.00163	0.00626	CcSEcCtD
Mexiletine—Angina pectoris—Procarbazine—brain cancer	0.00163	0.00626	CcSEcCtD
Mexiletine—SCN2A—pituitary gland—brain cancer	0.00157	0.0213	CbGeAlD
Mexiletine—Numbness—Etoposide—brain cancer	0.00155	0.00598	CcSEcCtD
Mexiletine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00153	0.0325	CbGpPWpGaD
Mexiletine—SCN2A—medulla oblongata—brain cancer	0.00152	0.0206	CbGeAlD
Mexiletine—SCN10A—pituitary gland—brain cancer	0.00152	0.0205	CbGeAlD
Mexiletine—AHR—endocrine gland—brain cancer	0.00151	0.0204	CbGeAlD
Mexiletine—Drowsiness—Procarbazine—brain cancer	0.00149	0.00573	CcSEcCtD
Mexiletine—Sensory loss—Etoposide—brain cancer	0.00149	0.00572	CcSEcCtD
Mexiletine—Thrombocytopenia—Lomustine—brain cancer	0.00146	0.00564	CcSEcCtD
Mexiletine—Pain—Carboplatin—brain cancer	0.00146	0.00563	CcSEcCtD
Mexiletine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.0014	0.0297	CbGpPWpGaD
Mexiletine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00139	0.0295	CbGpPWpGaD
Mexiletine—SCN2A—midbrain—brain cancer	0.00139	0.0188	CbGeAlD
Mexiletine—SCN4A—head—brain cancer	0.00136	0.0184	CbGeAlD
Mexiletine—SCN2A—spinal cord—brain cancer	0.00135	0.0183	CbGeAlD
Mexiletine—Body temperature increased—Carboplatin—brain cancer	0.00135	0.0052	CcSEcCtD
Mexiletine—Hallucination—Procarbazine—brain cancer	0.00133	0.00512	CcSEcCtD
Mexiletine—AHR—cerebellum—brain cancer	0.00133	0.018	CbGeAlD
Mexiletine—SCN10A—spinal cord—brain cancer	0.00131	0.0177	CbGeAlD
Mexiletine—Amnesia—Carmustine—brain cancer	0.00129	0.00495	CcSEcCtD
Mexiletine—Pancreatitis—Hydroxyurea—brain cancer	0.00127	0.00488	CcSEcCtD
Mexiletine—CYP2D6—hindbrain—brain cancer	0.00125	0.0169	CbGeAlD
Mexiletine—Hot flush—Temozolomide—brain cancer	0.00125	0.00481	CcSEcCtD
Mexiletine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00125	0.0265	CbGpPWpGaD
Mexiletine—Amnesia—Temozolomide—brain cancer	0.00124	0.00479	CcSEcCtD
Mexiletine—SCN4A—central nervous system—brain cancer	0.00124	0.0168	CbGeAlD
Mexiletine—Dermatitis exfoliative—Temozolomide—brain cancer	0.00124	0.00477	CcSEcCtD
Mexiletine—Menopausal symptoms—Temozolomide—brain cancer	0.00124	0.00477	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00123	0.0261	CbGpPWpGaD
Mexiletine—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.00122	0.0259	CbGpPWpGaD
Mexiletine—SCN2A—endocrine gland—brain cancer	0.00122	0.0165	CbGeAlD
Mexiletine—Neutropenia—Hydroxyurea—brain cancer	0.00121	0.00465	CcSEcCtD
Mexiletine—SCN2A—head—brain cancer	0.0012	0.0163	CbGeAlD
Mexiletine—Arrhythmia—Procarbazine—brain cancer	0.00119	0.0046	CcSEcCtD
Mexiletine—Body temperature increased—Lomustine—brain cancer	0.00118	0.00455	CcSEcCtD
Mexiletine—Alopecia—Procarbazine—brain cancer	0.00118	0.00455	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—NTRK3—brain cancer	0.00118	0.0251	CbGpPWpGaD
Mexiletine—SCN10A—endocrine gland—brain cancer	0.00118	0.0159	CbGeAlD
Mexiletine—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00117	0.0249	CbGpPWpGaD
Mexiletine—SCN10A—head—brain cancer	0.00116	0.0157	CbGeAlD
Mexiletine—Drowsiness—Hydroxyurea—brain cancer	0.00115	0.00444	CcSEcCtD
Mexiletine—Tension—Procarbazine—brain cancer	0.00114	0.0044	CcSEcCtD
Mexiletine—Ataxia—Carmustine—brain cancer	0.00114	0.00438	CcSEcCtD
Mexiletine—Nervousness—Procarbazine—brain cancer	0.00113	0.00435	CcSEcCtD
Mexiletine—Liver function test abnormal—Carmustine—brain cancer	0.00112	0.0043	CcSEcCtD
Mexiletine—SCN9A—brain—brain cancer	0.0011	0.015	CbGeAlD
Mexiletine—SCN2A—central nervous system—brain cancer	0.0011	0.0149	CbGeAlD
Mexiletine—Ataxia—Temozolomide—brain cancer	0.0011	0.00423	CcSEcCtD
Mexiletine—Tremor—Procarbazine—brain cancer	0.00109	0.0042	CcSEcCtD
Mexiletine—AHR—brain—brain cancer	0.00108	0.0146	CbGeAlD
Mexiletine—SCN2A—cerebellum—brain cancer	0.00107	0.0145	CbGeAlD
Mexiletine—Dry skin—Temozolomide—brain cancer	0.00107	0.00412	CcSEcCtD
Mexiletine—SCN10A—central nervous system—brain cancer	0.00106	0.0143	CbGeAlD
Mexiletine—SCN5A—head—brain cancer	0.00105	0.0143	CbGeAlD
Mexiletine—Dysphagia—Carmustine—brain cancer	0.00104	0.00402	CcSEcCtD
Mexiletine—Syncope—Procarbazine—brain cancer	0.00104	0.00402	CcSEcCtD
Mexiletine—Leukopenia—Procarbazine—brain cancer	0.00104	0.00401	CcSEcCtD
Mexiletine—Cardiac failure congestive—Etoposide—brain cancer	0.00103	0.00397	CcSEcCtD
Mexiletine—Hallucination—Hydroxyurea—brain cancer	0.00103	0.00396	CcSEcCtD
Mexiletine—Loss of consciousness—Procarbazine—brain cancer	0.00102	0.00394	CcSEcCtD
Mexiletine—Dysphagia—Temozolomide—brain cancer	0.00101	0.00389	CcSEcCtD
Mexiletine—Convulsion—Procarbazine—brain cancer	0.00101	0.00388	CcSEcCtD
Mexiletine—Hypertension—Procarbazine—brain cancer	0.001	0.00387	CcSEcCtD
Mexiletine—Arthralgia—Procarbazine—brain cancer	0.00099	0.00381	CcSEcCtD
Mexiletine—SCN4A—brain—brain cancer	0.000985	0.0133	CbGeAlD
Mexiletine—Sweating increased—Temozolomide—brain cancer	0.000983	0.00379	CcSEcCtD
Mexiletine—Neutropenia—Carmustine—brain cancer	0.000976	0.00376	CcSEcCtD
Mexiletine—Dry mouth—Procarbazine—brain cancer	0.000968	0.00373	CcSEcCtD
Mexiletine—SCN5A—central nervous system—brain cancer	0.000963	0.013	CbGeAlD
Mexiletine—Confusional state—Procarbazine—brain cancer	0.000957	0.00369	CcSEcCtD
Mexiletine—Vomiting—Lomustine—brain cancer	0.00095	0.00366	CcSEcCtD
Mexiletine—Oedema—Procarbazine—brain cancer	0.000949	0.00366	CcSEcCtD
Mexiletine—Neutropenia—Temozolomide—brain cancer	0.000943	0.00363	CcSEcCtD
Mexiletine—Shock—Procarbazine—brain cancer	0.000933	0.0036	CcSEcCtD
Mexiletine—Erectile dysfunction—Temozolomide—brain cancer	0.000929	0.00358	CcSEcCtD
Mexiletine—Thrombocytopenia—Procarbazine—brain cancer	0.000929	0.00358	CcSEcCtD
Mexiletine—Depression—Carmustine—brain cancer	0.000928	0.00358	CcSEcCtD
Mexiletine—Hyperhidrosis—Procarbazine—brain cancer	0.000917	0.00353	CcSEcCtD
Mexiletine—Alopecia—Hydroxyurea—brain cancer	0.000913	0.00352	CcSEcCtD
Mexiletine—Depression—Temozolomide—brain cancer	0.000897	0.00346	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000892	0.00344	CcSEcCtD
Mexiletine—Nausea—Lomustine—brain cancer	0.000888	0.00342	CcSEcCtD
Mexiletine—Hypotension—Procarbazine—brain cancer	0.000887	0.00342	CcSEcCtD
Mexiletine—SCN2A—brain—brain cancer	0.000872	0.0118	CbGeAlD
Mexiletine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000866	0.0184	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000864	0.00333	CcSEcCtD
Mexiletine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000855	0.0182	CbGpPWpGaD
Mexiletine—Paraesthesia—Procarbazine—brain cancer	0.000852	0.00328	CcSEcCtD
Mexiletine—Somnolence—Procarbazine—brain cancer	0.000843	0.00325	CcSEcCtD
Mexiletine—Cramp muscle—Etoposide—brain cancer	0.000841	0.00324	CcSEcCtD
Mexiletine—SCN10A—brain—brain cancer	0.000841	0.0114	CbGeAlD
Mexiletine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000835	0.00322	CcSEcCtD
Mexiletine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000833	0.0177	CbGpPWpGaD
Mexiletine—Hallucination—Carmustine—brain cancer	0.000831	0.0032	CcSEcCtD
Mexiletine—Hypoaesthesia—Carmustine—brain cancer	0.000831	0.0032	CcSEcCtD
Mexiletine—Fatigue—Procarbazine—brain cancer	0.000818	0.00315	CcSEcCtD
Mexiletine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000815	0.0173	CbGpPWpGaD
Mexiletine—Malaise—Hydroxyurea—brain cancer	0.000811	0.00313	CcSEcCtD
Mexiletine—Pain—Procarbazine—brain cancer	0.000811	0.00313	CcSEcCtD
Mexiletine—Constipation—Procarbazine—brain cancer	0.000811	0.00313	CcSEcCtD
Mexiletine—Hepatitis—Temozolomide—brain cancer	0.000807	0.00311	CcSEcCtD
Mexiletine—Dysphagia—Etoposide—brain cancer	0.000807	0.00311	CcSEcCtD
Mexiletine—Leukopenia—Hydroxyurea—brain cancer	0.000805	0.0031	CcSEcCtD
Mexiletine—Visual impairment—Carmustine—brain cancer	0.000805	0.0031	CcSEcCtD
Mexiletine—Hallucination—Temozolomide—brain cancer	0.000803	0.0031	CcSEcCtD
Mexiletine—Hypoaesthesia—Temozolomide—brain cancer	0.000803	0.0031	CcSEcCtD
Mexiletine—CYP2E1—telencephalon—brain cancer	0.000802	0.0109	CbGeAlD
Mexiletine—Pharyngitis—Temozolomide—brain cancer	0.000801	0.00309	CcSEcCtD
Mexiletine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000798	0.017	CbGpPWpGaD
Mexiletine—Sweating increased—Etoposide—brain cancer	0.000786	0.00303	CcSEcCtD
Mexiletine—Feeling abnormal—Procarbazine—brain cancer	0.000782	0.00301	CcSEcCtD
Mexiletine—Convulsion—Hydroxyurea—brain cancer	0.00078	0.003	CcSEcCtD
Mexiletine—Visual impairment—Temozolomide—brain cancer	0.000778	0.003	CcSEcCtD
Mexiletine—Gastrointestinal pain—Procarbazine—brain cancer	0.000776	0.00299	CcSEcCtD
Mexiletine—SCN5A—brain—brain cancer	0.000764	0.0103	CbGeAlD
Mexiletine—Erythema multiforme—Temozolomide—brain cancer	0.000763	0.00294	CcSEcCtD
Mexiletine—Discomfort—Hydroxyurea—brain cancer	0.000757	0.00292	CcSEcCtD
Mexiletine—Neutropenia—Etoposide—brain cancer	0.000755	0.00291	CcSEcCtD
Mexiletine—Tinnitus—Temozolomide—brain cancer	0.000753	0.0029	CcSEcCtD
Mexiletine—Abdominal pain—Procarbazine—brain cancer	0.00075	0.00289	CcSEcCtD
Mexiletine—Body temperature increased—Procarbazine—brain cancer	0.00075	0.00289	CcSEcCtD
Mexiletine—Arrhythmia—Carmustine—brain cancer	0.000746	0.00288	CcSEcCtD
Mexiletine—Alopecia—Carmustine—brain cancer	0.000738	0.00285	CcSEcCtD
Mexiletine—Oedema—Hydroxyurea—brain cancer	0.000734	0.00283	CcSEcCtD
Mexiletine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000734	0.0156	CbGpPWpGaD
Mexiletine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000719	0.00277	CcSEcCtD
Mexiletine—CYP2D6—brainstem—brain cancer	0.000716	0.00969	CbGeAlD
Mexiletine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000714	0.00275	CcSEcCtD
Mexiletine—Alopecia—Temozolomide—brain cancer	0.000713	0.00275	CcSEcCtD
Mexiletine—CYP2B6—gonad—brain cancer	0.000713	0.00966	CbGeAlD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000709	0.0151	CbGpPWpGaD
Mexiletine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000706	0.015	CbGpPWpGaD
Mexiletine—Hypersensitivity—Procarbazine—brain cancer	0.000699	0.00269	CcSEcCtD
Mexiletine—Dysgeusia—Temozolomide—brain cancer	0.000688	0.00265	CcSEcCtD
Mexiletine—Vision blurred—Carmustine—brain cancer	0.000685	0.00264	CcSEcCtD
Mexiletine—Tremor—Carmustine—brain cancer	0.000681	0.00263	CcSEcCtD
Mexiletine—Asthenia—Procarbazine—brain cancer	0.000681	0.00262	CcSEcCtD
Mexiletine—Agranulocytosis—Etoposide—brain cancer	0.000672	0.00259	CcSEcCtD
Mexiletine—Vision blurred—Temozolomide—brain cancer	0.000662	0.00255	CcSEcCtD
Mexiletine—Tremor—Temozolomide—brain cancer	0.000659	0.00254	CcSEcCtD
Mexiletine—Dyspnoea—Hydroxyurea—brain cancer	0.000655	0.00252	CcSEcCtD
Mexiletine—Somnolence—Hydroxyurea—brain cancer	0.000653	0.00252	CcSEcCtD
Mexiletine—Ill-defined disorder—Temozolomide—brain cancer	0.000652	0.00251	CcSEcCtD
Mexiletine—Leukopenia—Carmustine—brain cancer	0.000651	0.00251	CcSEcCtD
Mexiletine—Diarrhoea—Procarbazine—brain cancer	0.000649	0.0025	CcSEcCtD
Mexiletine—Dyspepsia—Hydroxyurea—brain cancer	0.000646	0.00249	CcSEcCtD
Mexiletine—Hypoaesthesia—Etoposide—brain cancer	0.000643	0.00248	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000638	0.0136	CbGpPWpGaD
Mexiletine—CYP2D6—telencephalon—brain cancer	0.000635	0.0086	CbGeAlD
Mexiletine—Malaise—Temozolomide—brain cancer	0.000634	0.00244	CcSEcCtD
Mexiletine—Fatigue—Hydroxyurea—brain cancer	0.000633	0.00244	CcSEcCtD
Mexiletine—Convulsion—Carmustine—brain cancer	0.00063	0.00243	CcSEcCtD
Mexiletine—CYP2E1—medulla oblongata—brain cancer	0.00063	0.00853	CbGeAlD
Mexiletine—Leukopenia—Temozolomide—brain cancer	0.000629	0.00242	CcSEcCtD
Mexiletine—Hypertension—Carmustine—brain cancer	0.000628	0.00242	CcSEcCtD
Mexiletine—Constipation—Hydroxyurea—brain cancer	0.000628	0.00242	CcSEcCtD
Mexiletine—Pain—Hydroxyurea—brain cancer	0.000628	0.00242	CcSEcCtD
Mexiletine—Dizziness—Procarbazine—brain cancer	0.000627	0.00242	CcSEcCtD
Mexiletine—Palpitations—Temozolomide—brain cancer	0.000621	0.00239	CcSEcCtD
Mexiletine—Chest pain—Carmustine—brain cancer	0.000619	0.00239	CcSEcCtD
Mexiletine—Erythema multiforme—Etoposide—brain cancer	0.000611	0.00235	CcSEcCtD
Mexiletine—Convulsion—Temozolomide—brain cancer	0.000609	0.00235	CcSEcCtD
Mexiletine—Hypertension—Temozolomide—brain cancer	0.000607	0.00234	CcSEcCtD
Mexiletine—Feeling abnormal—Hydroxyurea—brain cancer	0.000605	0.00233	CcSEcCtD
Mexiletine—Vomiting—Procarbazine—brain cancer	0.000603	0.00232	CcSEcCtD
Mexiletine—Confusional state—Carmustine—brain cancer	0.000599	0.00231	CcSEcCtD
Mexiletine—Arthralgia—Temozolomide—brain cancer	0.000598	0.00231	CcSEcCtD
Mexiletine—Rash—Procarbazine—brain cancer	0.000598	0.00231	CcSEcCtD
Mexiletine—Dermatitis—Procarbazine—brain cancer	0.000598	0.0023	CcSEcCtD
Mexiletine—Headache—Procarbazine—brain cancer	0.000594	0.00229	CcSEcCtD
Mexiletine—Oedema—Carmustine—brain cancer	0.000594	0.00229	CcSEcCtD
Mexiletine—Discomfort—Temozolomide—brain cancer	0.000591	0.00228	CcSEcCtD
Mexiletine—Dry mouth—Temozolomide—brain cancer	0.000585	0.00226	CcSEcCtD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—HES5—brain cancer	0.000584	0.0124	CbGpPWpGaD
Mexiletine—Thrombocytopenia—Carmustine—brain cancer	0.000581	0.00224	CcSEcCtD
Mexiletine—Body temperature increased—Hydroxyurea—brain cancer	0.00058	0.00224	CcSEcCtD
Mexiletine—Confusional state—Temozolomide—brain cancer	0.000578	0.00223	CcSEcCtD
Mexiletine—Oedema—Temozolomide—brain cancer	0.000574	0.00221	CcSEcCtD
Mexiletine—Alopecia—Etoposide—brain cancer	0.000571	0.0022	CcSEcCtD
Mexiletine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000566	0.012	CbGpPWpGaD
Mexiletine—Nausea—Procarbazine—brain cancer	0.000564	0.00217	CcSEcCtD
Mexiletine—CYP1A2—endocrine gland—brain cancer	0.000562	0.00762	CbGeAlD
Mexiletine—CYP2E1—spinal cord—brain cancer	0.000562	0.00761	CbGeAlD
Mexiletine—Thrombocytopenia—Temozolomide—brain cancer	0.000562	0.00216	CcSEcCtD
Mexiletine—Hypotension—Carmustine—brain cancer	0.000555	0.00214	CcSEcCtD
Mexiletine—Hyperhidrosis—Temozolomide—brain cancer	0.000555	0.00214	CcSEcCtD
Mexiletine—Dysgeusia—Etoposide—brain cancer	0.000551	0.00212	CcSEcCtD
Mexiletine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000545	0.0116	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000542	0.0115	CbGpPWpGaD
Mexiletine—Hypersensitivity—Hydroxyurea—brain cancer	0.000541	0.00208	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000541	0.00208	CcSEcCtD
Mexiletine—Muscle spasms—Etoposide—brain cancer	0.000541	0.00208	CcSEcCtD
Mexiletine—CYP2B6—endocrine gland—brain cancer	0.000539	0.0073	CbGeAlD
Mexiletine—Paraesthesia—Carmustine—brain cancer	0.000533	0.00205	CcSEcCtD
Mexiletine—CYP2B6—head—brain cancer	0.000532	0.00721	CbGeAlD
Mexiletine—Dyspnoea—Carmustine—brain cancer	0.000529	0.00204	CcSEcCtD
Mexiletine—Somnolence—Carmustine—brain cancer	0.000528	0.00203	CcSEcCtD
Mexiletine—Asthenia—Hydroxyurea—brain cancer	0.000527	0.00203	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000523	0.00201	CcSEcCtD
Mexiletine—Ill-defined disorder—Etoposide—brain cancer	0.000522	0.00201	CcSEcCtD
Mexiletine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000517	0.011	CbGpPWpGaD
Mexiletine—Paraesthesia—Temozolomide—brain cancer	0.000515	0.00198	CcSEcCtD
Mexiletine—Dyspnoea—Temozolomide—brain cancer	0.000511	0.00197	CcSEcCtD
Mexiletine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000511	0.0109	CbGpPWpGaD
Mexiletine—Somnolence—Temozolomide—brain cancer	0.00051	0.00197	CcSEcCtD
Mexiletine—Constipation—Carmustine—brain cancer	0.000508	0.00196	CcSEcCtD
Mexiletine—Pain—Carmustine—brain cancer	0.000508	0.00196	CcSEcCtD
Mexiletine—Malaise—Etoposide—brain cancer	0.000507	0.00195	CcSEcCtD
Mexiletine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000507	0.0108	CbGpPWpGaD
Mexiletine—CYP2E1—endocrine gland—brain cancer	0.000506	0.00685	CbGeAlD
Mexiletine—Dyspepsia—Temozolomide—brain cancer	0.000505	0.00195	CcSEcCtD
Mexiletine—Leukopenia—Etoposide—brain cancer	0.000503	0.00194	CcSEcCtD
Mexiletine—Diarrhoea—Hydroxyurea—brain cancer	0.000502	0.00194	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000502	0.0107	CbGpPWpGaD
Mexiletine—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.0005	0.0106	CbGpPWpGaD
Mexiletine—CYP2E1—head—brain cancer	0.000499	0.00676	CbGeAlD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000499	0.0106	CbGpPWpGaD
Mexiletine—Fatigue—Temozolomide—brain cancer	0.000495	0.00191	CcSEcCtD
Mexiletine—Loss of consciousness—Etoposide—brain cancer	0.000494	0.0019	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000492	0.0105	CbGpPWpGaD
Mexiletine—Pain—Temozolomide—brain cancer	0.000491	0.00189	CcSEcCtD
Mexiletine—Constipation—Temozolomide—brain cancer	0.000491	0.00189	CcSEcCtD
Mexiletine—Feeling abnormal—Carmustine—brain cancer	0.000489	0.00188	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000488	0.0104	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000488	0.0104	CbGpPWpGaD
Mexiletine—Convulsion—Etoposide—brain cancer	0.000487	0.00188	CcSEcCtD
Mexiletine—CYP2B6—central nervous system—brain cancer	0.000486	0.00658	CbGeAlD
Mexiletine—Hypertension—Etoposide—brain cancer	0.000486	0.00187	CcSEcCtD
Mexiletine—Dizziness—Hydroxyurea—brain cancer	0.000486	0.00187	CcSEcCtD
Mexiletine—Gastrointestinal pain—Carmustine—brain cancer	0.000485	0.00187	CcSEcCtD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00048	0.0102	CbGpPWpGaD
Mexiletine—Chest pain—Etoposide—brain cancer	0.000479	0.00185	CcSEcCtD
Mexiletine—Discomfort—Etoposide—brain cancer	0.000473	0.00182	CcSEcCtD
Mexiletine—Feeling abnormal—Temozolomide—brain cancer	0.000473	0.00182	CcSEcCtD
Mexiletine—Abdominal pain—Carmustine—brain cancer	0.000469	0.00181	CcSEcCtD
Mexiletine—Body temperature increased—Carmustine—brain cancer	0.000469	0.00181	CcSEcCtD
Mexiletine—Gastrointestinal pain—Temozolomide—brain cancer	0.000469	0.00181	CcSEcCtD
Mexiletine—Vomiting—Hydroxyurea—brain cancer	0.000467	0.0018	CcSEcCtD
Mexiletine—Rash—Hydroxyurea—brain cancer	0.000463	0.00178	CcSEcCtD
Mexiletine—Confusional state—Etoposide—brain cancer	0.000463	0.00178	CcSEcCtD
Mexiletine—Dermatitis—Hydroxyurea—brain cancer	0.000463	0.00178	CcSEcCtD
Mexiletine—Headache—Hydroxyurea—brain cancer	0.00046	0.00177	CcSEcCtD
Mexiletine—CYP2E1—central nervous system—brain cancer	0.000456	0.00617	CbGeAlD
Mexiletine—Abdominal pain—Temozolomide—brain cancer	0.000453	0.00175	CcSEcCtD
Mexiletine—Body temperature increased—Temozolomide—brain cancer	0.000453	0.00175	CcSEcCtD
Mexiletine—Thrombocytopenia—Etoposide—brain cancer	0.000449	0.00173	CcSEcCtD
Mexiletine—AHR—Adipogenesis—IRS2—brain cancer	0.000447	0.00951	CbGpPWpGaD
Mexiletine—CYP2E1—cerebellum—brain cancer	0.000446	0.00603	CbGeAlD
Mexiletine—Hyperhidrosis—Etoposide—brain cancer	0.000444	0.00171	CcSEcCtD
Mexiletine—Hypersensitivity—Carmustine—brain cancer	0.000437	0.00169	CcSEcCtD
Mexiletine—Nausea—Hydroxyurea—brain cancer	0.000436	0.00168	CcSEcCtD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—brain cancer	0.000436	0.00927	CbGpPWpGaD
Mexiletine—Hypotension—Etoposide—brain cancer	0.000429	0.00165	CcSEcCtD
Mexiletine—Asthenia—Carmustine—brain cancer	0.000426	0.00164	CcSEcCtD
Mexiletine—Hypersensitivity—Temozolomide—brain cancer	0.000423	0.00163	CcSEcCtD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000419	0.00892	CbGpPWpGaD
Mexiletine—Paraesthesia—Etoposide—brain cancer	0.000412	0.00159	CcSEcCtD
Mexiletine—Asthenia—Temozolomide—brain cancer	0.000412	0.00159	CcSEcCtD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000411	0.00873	CbGpPWpGaD
Mexiletine—Dyspnoea—Etoposide—brain cancer	0.000409	0.00158	CcSEcCtD
Mexiletine—Somnolence—Etoposide—brain cancer	0.000408	0.00157	CcSEcCtD
Mexiletine—CYP3A4—endocrine gland—brain cancer	0.000407	0.00551	CbGeAlD
Mexiletine—Diarrhoea—Carmustine—brain cancer	0.000406	0.00157	CcSEcCtD
Mexiletine—CYP2D6—endocrine gland—brain cancer	0.000401	0.00542	CbGeAlD
Mexiletine—Fatigue—Etoposide—brain cancer	0.000396	0.00152	CcSEcCtD
Mexiletine—CYP2D6—head—brain cancer	0.000395	0.00535	CbGeAlD
Mexiletine—Dizziness—Carmustine—brain cancer	0.000393	0.00151	CcSEcCtD
Mexiletine—Constipation—Etoposide—brain cancer	0.000393	0.00151	CcSEcCtD
Mexiletine—Pain—Etoposide—brain cancer	0.000393	0.00151	CcSEcCtD
Mexiletine—Diarrhoea—Temozolomide—brain cancer	0.000392	0.00151	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—SIRT1—brain cancer	0.000392	0.00832	CbGpPWpGaD
Mexiletine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000389	0.00826	CbGpPWpGaD
Mexiletine—CYP2B6—brain—brain cancer	0.000386	0.00522	CbGeAlD
Mexiletine—Dizziness—Temozolomide—brain cancer	0.000379	0.00146	CcSEcCtD
Mexiletine—Feeling abnormal—Etoposide—brain cancer	0.000378	0.00146	CcSEcCtD
Mexiletine—Vomiting—Carmustine—brain cancer	0.000377	0.00145	CcSEcCtD
Mexiletine—Gastrointestinal pain—Etoposide—brain cancer	0.000375	0.00145	CcSEcCtD
Mexiletine—Rash—Carmustine—brain cancer	0.000374	0.00144	CcSEcCtD
Mexiletine—Dermatitis—Carmustine—brain cancer	0.000374	0.00144	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000372	0.00791	CbGpPWpGaD
Mexiletine—Headache—Carmustine—brain cancer	0.000372	0.00143	CcSEcCtD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00037	0.00787	CbGpPWpGaD
Mexiletine—CYP3A4—central nervous system—brain cancer	0.000367	0.00497	CbGeAlD
Mexiletine—Vomiting—Temozolomide—brain cancer	0.000365	0.00141	CcSEcCtD
Mexiletine—Abdominal pain—Etoposide—brain cancer	0.000363	0.0014	CcSEcCtD
Mexiletine—Body temperature increased—Etoposide—brain cancer	0.000363	0.0014	CcSEcCtD
Mexiletine—CYP2E1—brain—brain cancer	0.000362	0.0049	CbGeAlD
Mexiletine—Rash—Temozolomide—brain cancer	0.000362	0.00139	CcSEcCtD
Mexiletine—Dermatitis—Temozolomide—brain cancer	0.000361	0.00139	CcSEcCtD
Mexiletine—CYP2D6—central nervous system—brain cancer	0.000361	0.00489	CbGeAlD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00036	0.00764	CbGpPWpGaD
Mexiletine—Headache—Temozolomide—brain cancer	0.000359	0.00138	CcSEcCtD
Mexiletine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000355	0.00754	CbGpPWpGaD
Mexiletine—CYP2D6—cerebellum—brain cancer	0.000353	0.00478	CbGeAlD
Mexiletine—Nausea—Carmustine—brain cancer	0.000353	0.00136	CcSEcCtD
Mexiletine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000352	0.00749	CbGpPWpGaD
Mexiletine—Nausea—Temozolomide—brain cancer	0.000341	0.00131	CcSEcCtD
Mexiletine—Hypersensitivity—Etoposide—brain cancer	0.000338	0.0013	CcSEcCtD
Mexiletine—Asthenia—Etoposide—brain cancer	0.000329	0.00127	CcSEcCtD
Mexiletine—Diarrhoea—Etoposide—brain cancer	0.000314	0.00121	CcSEcCtD
Mexiletine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000305	0.00648	CbGpPWpGaD
Mexiletine—Dizziness—Etoposide—brain cancer	0.000304	0.00117	CcSEcCtD
Mexiletine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000301	0.00639	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—CDK4—brain cancer	0.000296	0.0063	CbGpPWpGaD
Mexiletine—Vomiting—Etoposide—brain cancer	0.000292	0.00112	CcSEcCtD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000292	0.0062	CbGpPWpGaD
Mexiletine—Rash—Etoposide—brain cancer	0.000289	0.00112	CcSEcCtD
Mexiletine—Dermatitis—Etoposide—brain cancer	0.000289	0.00111	CcSEcCtD
Mexiletine—Headache—Etoposide—brain cancer	0.000288	0.00111	CcSEcCtD
Mexiletine—CYP2D6—brain—brain cancer	0.000287	0.00388	CbGeAlD
Mexiletine—Nausea—Etoposide—brain cancer	0.000273	0.00105	CcSEcCtD
Mexiletine—AHR—Adipogenesis—CTNNB1—brain cancer	0.000268	0.00571	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—TRPC6—brain cancer	0.000268	0.0057	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000249	0.00529	CbGpPWpGaD
Mexiletine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000247	0.00525	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—TRPC6—brain cancer	0.000246	0.00524	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—TRPC6—brain cancer	0.000246	0.00524	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.00024	0.00511	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000238	0.00506	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—TRPC6—brain cancer	0.000238	0.00505	CbGpPWpGaD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000235	0.005	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—STAT3—brain cancer	0.000234	0.00497	CbGpPWpGaD
Mexiletine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000232	0.00493	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000223	0.00474	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.00022	0.00467	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000218	0.00464	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000215	0.00457	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.00021	0.00446	CbGpPWpGaD
Mexiletine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.0002	0.00424	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000193	0.0041	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000193	0.0041	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TRPC6—brain cancer	0.000191	0.00407	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000191	0.00405	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000189	0.00401	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—EGFR—brain cancer	0.000182	0.00386	CbGpPWpGaD
Mexiletine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000177	0.00376	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TRPC6—brain cancer	0.000176	0.00374	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TRPC6—brain cancer	0.000176	0.00374	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TRPC6—brain cancer	0.000169	0.0036	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—TRPC6—brain cancer	0.000167	0.00355	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—EGFR—brain cancer	0.000167	0.00355	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—EGFR—brain cancer	0.000167	0.00355	CbGpPWpGaD
Mexiletine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000163	0.00346	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—EGFR—brain cancer	0.000161	0.00342	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000158	0.00337	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000155	0.00329	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000153	0.00325	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000135	0.00288	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000131	0.00279	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000129	0.00275	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TP53—brain cancer	0.000126	0.00268	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HES1—brain cancer	0.000123	0.00262	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TRPC6—brain cancer	0.000119	0.00253	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HES1—brain cancer	0.000113	0.00241	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HES1—brain cancer	0.000113	0.00241	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—EGFR—brain cancer	0.000113	0.0024	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HES1—brain cancer	0.000109	0.00232	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000101	0.00215	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	9.99e-05	0.00212	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—ERBB2—brain cancer	9.9e-05	0.0021	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	9.68e-05	0.00206	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CDK4—brain cancer	9.67e-05	0.00205	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—ERBB2—brain cancer	9.1e-05	0.00193	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—ERBB2—brain cancer	9.1e-05	0.00193	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CDK4—brain cancer	8.88e-05	0.00189	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CDK4—brain cancer	8.88e-05	0.00189	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—ERBB2—brain cancer	8.77e-05	0.00187	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CDK4—brain cancer	8.57e-05	0.00182	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	8.53e-05	0.00181	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.81e-05	0.00166	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HES1—brain cancer	7.68e-05	0.00163	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—VEGFA—brain cancer	7.63e-05	0.00162	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—RELA—brain cancer	7.11e-05	0.00151	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—ERBB2—brain cancer	7.07e-05	0.0015	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.03e-05	0.00149	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—VEGFA—brain cancer	7.01e-05	0.00149	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—VEGFA—brain cancer	7.01e-05	0.00149	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—EGFR—brain cancer	6.86e-05	0.00146	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—VEGFA—brain cancer	6.76e-05	0.00144	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—RELA—brain cancer	6.53e-05	0.00139	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—RELA—brain cancer	6.53e-05	0.00139	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—ERBB2—brain cancer	6.49e-05	0.00138	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—ERBB2—brain cancer	6.49e-05	0.00138	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EGFR—brain cancer	6.31e-05	0.00134	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EGFR—brain cancer	6.31e-05	0.00134	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—RELA—brain cancer	6.3e-05	0.00134	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—ERBB2—brain cancer	6.26e-05	0.00133	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CTNNB1—brain cancer	6.18e-05	0.00131	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—ERBB2—brain cancer	6.17e-05	0.00131	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—EGFR—brain cancer	6.08e-05	0.00129	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CDK4—brain cancer	6.02e-05	0.00128	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.97e-05	0.00127	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CTNNB1—brain cancer	5.68e-05	0.00121	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CTNNB1—brain cancer	5.68e-05	0.00121	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.5e-05	0.00117	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CTNNB1—brain cancer	5.48e-05	0.00116	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—VEGFA—brain cancer	5.44e-05	0.00116	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—STAT3—brain cancer	5.39e-05	0.00115	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.38e-05	0.00114	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.38e-05	0.00114	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.04e-05	0.00107	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—VEGFA—brain cancer	5e-05	0.00106	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—VEGFA—brain cancer	5e-05	0.00106	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—STAT3—brain cancer	4.95e-05	0.00105	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—STAT3—brain cancer	4.95e-05	0.00105	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EGFR—brain cancer	4.9e-05	0.00104	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—VEGFA—brain cancer	4.82e-05	0.00103	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—STAT3—brain cancer	4.77e-05	0.00101	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—VEGFA—brain cancer	4.75e-05	0.00101	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EGFR—brain cancer	4.5e-05	0.000957	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EGFR—brain cancer	4.5e-05	0.000957	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—RELA—brain cancer	4.43e-05	0.000942	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—ERBB2—brain cancer	4.4e-05	0.000936	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EGFR—brain cancer	4.34e-05	0.000922	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—EGFR—brain cancer	4.28e-05	0.000909	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CTNNB1—brain cancer	3.85e-05	0.000819	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP2C9—brain cancer	3.81e-05	0.00081	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP2C9—brain cancer	3.73e-05	0.000793	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.68e-05	0.000783	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—VEGFA—brain cancer	3.39e-05	0.000721	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—STAT3—brain cancer	3.36e-05	0.000714	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—BSG—brain cancer	3.24e-05	0.000689	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—BSG—brain cancer	3.17e-05	0.000675	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EGFR—brain cancer	3.05e-05	0.000649	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—IDH1—brain cancer	2.79e-05	0.000592	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—IDH1—brain cancer	2.73e-05	0.00058	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP2C9—brain cancer	2.65e-05	0.000563	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—BSG—brain cancer	2.25e-05	0.000479	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP2C9—brain cancer	2.24e-05	0.000477	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ENO2—brain cancer	2.2e-05	0.000468	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ENO2—brain cancer	2.16e-05	0.000459	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—IDH1—brain cancer	1.94e-05	0.000412	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—BSG—brain cancer	1.91e-05	0.000405	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.73e-05	0.000368	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—IDH1—brain cancer	1.64e-05	0.000349	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ENO2—brain cancer	1.53e-05	0.000325	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—BSG—brain cancer	1.47e-05	0.000313	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.34e-05	0.000284	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ENO2—brain cancer	1.3e-05	0.000276	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—IDH1—brain cancer	1.27e-05	0.000269	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CG—brain cancer	1.01e-05	0.000215	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ENO2—brain cancer	1e-05	0.000213	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CG—brain cancer	9.89e-06	0.00021	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CG—brain cancer	7.02e-06	0.000149	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CG—brain cancer	5.95e-06	0.000126	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CG—brain cancer	4.59e-06	9.76e-05	CbGpPWpGaD
